A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States
Public ClinicalTrials.gov record NCT07122193. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Parallel-Group, Double-Blind, Multicenter Study Investigating the Safety and Efficacy of NT 201 Compared With Placebo in Adult Participants With Moderate to Severe Platysma Prominence in the United States
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety and efficacy of NT 201 compared with placebo in participants with moderate to severe platysma prominence. The study will be conducted in two periods: Main Period (MP) and Open label Extension Period (OLEX).
Study identification
- NCT ID
- NCT07122193
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 26, 2025
- Primary completion
- Sep 30, 2026
- Completion
- Dec 31, 2027
- Last update posted
- May 21, 2026
2025 – 2028
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Merz Investigative Site | Scottsdale | Arizona | 85260 | — |
| Merz Investigative Site | Encino | California | 91436 | — |
| Merz Investigative Site | Los Angeles | California | 90069 | — |
| Merz Investigative Site | Redondo Beach | California | 90277 | — |
| Merz Investigative Site | Santa Monica | California | 90404 | — |
| Merz Investigative Site | Vista | California | 92803 | — |
| Merz Investigative Site | Greenwood Village | Colorado | 80111 | — |
| Merz Investigative Site | Westport | Connecticut | 06880 | — |
| Merz Investigative Site | Washington D.C. | District of Columbia | 20037 | — |
| Merz Investigative Site | Aventura | Florida | 33180 | — |
| Merz Investigative Site | Boca Raton | Florida | 33431 | — |
| Merz Investigative Site | Bradenton | Florida | 34209 | — |
| Merz Investigative Site | Coral Gables | Florida | 33143 | — |
| Merz Investigative Site | Coral Gables | Florida | 33146 | — |
| Merz Investigative Site | West Palm Beach | Florida | 33404 | — |
| Merz Investigative Site | Alpharetta | Georgia | 30005 | — |
| Merz Investigative Site | Naperville | Illinois | 60563 | — |
| Merz Investigative Site | Hunt Valley | Maryland | 21030 | — |
| Merz Investigative Site | Mount Kisco | New York | 10549 | — |
| Merz Investigative Site | New York | New York | 10021 | — |
| Merz Investigative Site | New York | New York | 10028 | — |
| Merz Investigative Site | Chapel Hill | North Carolina | 27517 | — |
| Merz Investigative Site | Wilmington | North Carolina | 28405 | — |
| Merz Investigative Site | Ardmore | Pennsylvania | 19003 | — |
| Merz Investigative Site | Nashville | Tennessee | 37215 | — |
| Merz Investigative Site | Dallas | Texas | 75225 | — |
| Merz Investigative Site | Arlington | Virginia | 22209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07122193, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 21, 2026 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07122193 live on ClinicalTrials.gov.